SCHEMBL217496

SCHEMBL217496

NNC(=O)c1ccc(NN)nc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NNMT P40261 1/20 0.49
MPO P05164 2/20 0.48
CYP3A4 P08684 2/20 0.48
KDM5A P29375 1/20 0.48
BLM P54132 1/20 0.48
GFER P55789 1/20 0.48
PMP22 Q01453 1/20 0.48
HIF1A Q16665 1/20 0.48
KDM4E B2RXH2 2/20 0.47
MAPT P10636 2/20 0.47
OGG1 O15527 1/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CYP1A2 P05177 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2A6 P11509 1/20 0.47
CYP2C19 P33261 1/20 0.47
HCAR3 P49019 7/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28117859 0.85 NNMT (0.46) NNMTHCAR3HDAC1HDAC6
SCHEMBL29424855 0.85 NNMT (0.54) NNMTHCAR3HDAC1HDAC6CA2
SCHEMBL4070958 0.85 HCAR3 (0.63) MPOCYP3A4KDM5ABLMGFER
SCHEMBL2487358 0.85 NNMT (0.54) NNMTHCAR3HDAC1HDAC6CA2
SCHEMBL9358442 0.85 KDM4E (0.42) NNMTCYP3A4KDM4EMAPTALDH1A1
SCHEMBL8126559 0.84 NNMT (0.42) NNMTKDM4EMAPTL3MBTL1HCAR3
SCHEMBL12388325 0.84 HCAR3 (0.51) NNMTHCAR3
SCHEMBL25212859 0.84 HCAR3 (0.53) NNMTMPOCYP3A4KDM5ABLM
SCHEMBL8722229 0.82 NNMT (0.50) NNMTKDM4EMAPTHCAR3HCAR2
SCHEMBL158601 0.82 HCAR3 (0.67) HCAR3HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250332290-A1 PSMA-TARGETING LIGANDS FOR MULTIMODAL APPLICATIONS STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM (NL) 2025-10-30 US disclosed
EP-4377368-B1 AQUEOUS POLYURETHANE DISPERSION ALLNEX AUSTRIA GMBH (AT) 2025-06-18 EP disclosed
US-20240369544-A1 MULTIVALENT GLYCAN SCAFFOLDS AND METHODS OF USE THEREOF NOVAB, INC. 2024-11-07 US disclosed
US-20240352178-A1 AQUEOUS POLYURETHANE DISPERSION ALLNEX AUSTRIA GMBH (AT) 2024-10-24 US disclosed
EP-4400523-A1 AQUEOUS POLYURETHANE-VINYL POLYMER HYBRID DISPERSION Allnex Austria GmbH (AT) 2024-07-17 EP disclosed
EP-4392777-A2 MULTIVALENT GLYCAN SCAFFOLDS AND METHODS OF USE THEREOF Novab, Inc. (US) 2024-07-03 EP disclosed
EP-4377368-A1 AQUEOUS POLYURETHANE DISPERSION Allnex Austria GmbH (AT) 2024-06-05 EP disclosed
CN-117642443-A Aqueous polyurethane dispersions 湛新奥地利有限公司 2024-03-01 CN disclosed
EP-4288116-A1 PSMA-TARGETING LIGANDS FOR MULTIMODAL APPLICATIONS Stichting Radboud universitair medisch centrum (NL) 2023-12-13 EP disclosed
CN-117157110-A PSMA targeting ligands for multimodal applications 荷兰拉德堡德大学学术医学中心 2023-12-01 CN disclosed
EP-2001963-A1 INKJET INK SET E.I. DU PONT DE NEMOURS AND COMPANY (US) 2008-12-17 EP disclosed
US-20070251423-A1 Aqueous Vinyl Polymer Coating Compositions DSM IP ASSETS B.V. (NL) 2007-11-01 US disclosed
WO-2007103542-A1 INKJET INK SET E. I. DU PONT DE NEMOURS AND COMPANY (US) 2007-09-13 WO disclosed
US-20070211126-A1 Inkjet ink set E. I. DU PONT DE NEMOURS AND COMPANY 2007-09-13 US disclosed
EP-1769039-A1 AQUEOUS VINYL POLYMER COATING COMPOSITIONS DSMIP Assets B.V. (NL) 2007-04-04 EP disclosed
WO-2006007978-A1 AQUEOUS VINYL POLYMER COATING COMPOSITIONS DSM IP ASSETS BV (NL) 2006-01-26 WO disclosed
EP-0332326-B1 POLYURETHANE COATING COMPOSITIONS ICI RESINS BV (NL) 1993-03-03 EP disclosed
US-4983662-A SELF-CROSSLINKING THROUGH HYDRAZINE OR HYDRAZONE AND CARBONYL FUNCTIONAL GROUPS ICI RESINS B.V. (NL) 1991-01-08 US disclosed
EP-0332326-A2 Polyurethane coating compositions ICI RESINS BV (NL) 1989-09-13 EP disclosed
US-4250070-A ALSO CONTAINING HEAVY METAL IONS; STORAGE STABILITY; CROSSLINKING; COATINGS BASF AKTIENGESELLSCHAFT (DE) 1981-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250332290-A1 PSMA-TARGETING LIGANDS FOR MULTIMODAL APPLICATIONS FOLH1, KLK3, PSMA2 NNMT 1728/4885MPO 4157/4885CYP3A4 4410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.